<VariationArchive VariationID="3247677" VariationName="NC_000001.10:g.(?_24122439)_(24144093_?)del" VariationType="Deletion" Accession="VCV003247677" Version="1" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3404187" VariationID="3247677">
      <GeneList>
        <Gene Symbol="GALE" FullName="UDP-galactose-4-epimerase" GeneID="2582" HGNC_ID="HGNC:4116" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1p36.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="23795599" stop="23800754" display_start="23795599" display_stop="23800754" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="24122088" stop="24127293" display_start="24122088" display_stop="24127293" Strand="-" />
          </Location>
          <OMIM>606953</OMIM>
        </Gene>
        <Gene Symbol="HMGCL" FullName="3-hydroxy-3-methylglutaryl-CoA lyase" GeneID="3155" HGNC_ID="HGNC:5005" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1p36.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="23801885" stop="23825429" display_start="23801885" display_stop="23825429" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="24128366" stop="24151948" display_start="24128366" display_stop="24151948" Strand="-" />
          </Location>
          <OMIM>613898</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000001.10:g.(?_24122439)_(24144093_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p36.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" innerStart="24122439" innerStop="24144093" display_start="24122439" display_stop="24144093" variantLength="21655" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.(?_24122439)_(24144093_?)del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.(?_24122439)_(24144093_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000001.10:g.(?_24122439)_(24144093_?)del AND Deficiency of hydroxymethylglutaryl-CoA lyase" Accession="RCV004583960" Version="1">
        <ClassifiedConditionList TraitSetID="3240">
          <ClassifiedCondition DB="MedGen" ID="C0268601">Deficiency of hydroxymethylglutaryl-CoA lyase</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000001.10:g.(?_24122439)_(24144093_?)del AND UDPglucose-4-epimerase deficiency" Accession="RCV004583959" Version="1">
        <ClassifiedConditionList TraitSetID="964">
          <ClassifiedCondition DB="MedGen" ID="C0751161">UDPglucose-4-epimerase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-22" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14518825</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16301867</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16330550</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9784232</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="964" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1907" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">UDP-Galactose-4-epimerase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Galactosemia 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">UDPglucose-4-epimerase deficiency</ElementValue>
                <XRef ID="Galactose+Epimerase+Deficiency/2972" DB="Genetic Alliance" />
                <XRef ID="8849004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GALACTOSEMIA III</ElementValue>
                <XRef Type="MIM" ID="230350" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606953.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606953.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606953.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606953.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606953.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606953.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606953.0002" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Galactose epimerase deficiency</ElementValue>
                <XRef ID="MONDO:0009257" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">UDPglucose 4-Epimerase Deficiency Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epimerase Deficiency Galactosemia</ElementValue>
                <XRef ID="NBK51671" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GALE</ElementValue>
                <XRef ID="GTR000331211" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Epimerase deficiency galactosemia (GALE deficiency galactosemia) is generally considered a continuum comprising several forms: Generalized. Enzyme activity is profoundly decreased in all tissues tested. Peripheral. Enzyme activity is deficient in red blood cells (RBC) and circulating white blood cells, but normal or near normal in all other tissues. Intermediate. Enzyme activity is deficient in red blood cells and circulating white blood cells and less than 50% of normal levels in other cells tested. Infants with generalized epimerase deficiency galactosemia develop clinical findings on a regular milk diet (which contains lactose, a disaccharide of galactose and glucose); manifestations include hypotonia, poor feeding, vomiting, weight loss, jaundice, hepatomegaly, liver dysfunction, aminoaciduria, and cataracts. Prompt removal of galactose/lactose from their diet resolves or prevents these acute symptoms. Longer-term features that may be seen in those with generalized epimerase deficiency include short stature, developmental delay, sensorineural hearing loss, and skeletal anomalies. In contrast, neonates with the peripheral or intermediate form generally remain clinically well even on a regular milk diet and are usually only identified by biochemical testing, often in newborn screening programs.</Attribute>
                <XRef ID="NBK51671" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5392" />
                <XRef ID="5392" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21290786</ID>
                <ID Source="BookShelf">NBK51671</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT Sheet, 2010">
                <URL>https://www.ncbi.nlm.nih.gov/books/NBK55827/bin/Galactose_GALT.pdf</URL>
                <CitationText>American College of Medical Genetics ACT SHEETs, Primary or Secondary Hypergalactosemia, 2010</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2009">
                <URL>https://www.ncbi.nlm.nih.gov/books/NBK55827/bin/Visio-GALT.pdf</URL>
                <CitationText>American College of Medical Genetics Algorithm, Primary or Secondary Hypergalactosemia, 2009</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Newborn-Screening-ACT-Sheet-Increased-Total-Galactose-with-normal-GALTPrimary-or-Secondary-Hypergala.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Newborn Screening ACT Sheet Primary or Secondary Hypergalactosemia</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Hypergalactosemia-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics Algorithm, Primary or Secondary Hypergalactosemia (Galactose Elevated)</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Galactose-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated total galactose with normal GALT enzyme activity, Primary or Secondary Hypergalactosemia, 2022</CitationText>
              </Citation>
              <XRef ID="352" DB="Orphanet" />
              <XRef ID="79238" DB="Orphanet" />
              <XRef ID="C0751161" DB="MedGen" />
              <XRef ID="MONDO:0009257" DB="MONDO" />
              <XRef Type="MIM" ID="230350" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3240" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14358" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HMGCL DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="246450" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Deficiency of hydroxymethylglutaryl-CoA lyase</ElementValue>
                <XRef ID="HMG+CoA+lyase+deficiency/3440" DB="Genetic Alliance" />
                <XRef ID="124611007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HMG CoA lyase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Defect in leucine metabolism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">3-hydroxy-3-methylglutaric aciduria</ElementValue>
                <XRef ID="MONDO:0009520" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hydroxymethylglutaric aciduria</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HMGCLD</ElementValue>
                <XRef Type="MIM" ID="246450" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8387" />
                <XRef ID="8387" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C5-OH Acylcarnitine, Organic Acidemias, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH-Elevated.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Organic Acidemias: Elevated C5-OH, 2022</CitationText>
              </Citation>
              <XRef ID="20" DB="Orphanet" />
              <XRef ID="C0268601" DB="MedGen" />
              <XRef ID="MONDO:0009520" DB="MONDO" />
              <XRef Type="MIM" ID="246450" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9838216" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000001.10:g.(?_24122439)_(24144093_?)del|MedGen:C0268601" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005065074" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8798725</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9784232</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14518825</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16330550</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 3-9 of the HMGCL gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the HMGCL protein in which other variant(s) (p.His233Arg) have been determined to be pathogenic (PMID: 8798725, 9784232, 14518825, 16330550). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with HMGCL-related conditions.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.(?_24122439)_(24144093_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268601" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9838251" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000001.10:g.(?_24122439)_(24144093_?)del|MedGen:C0751161" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005065109" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16301867</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with GALE-related conditions. A gross deletion of the genomic region encompassing the full coding sequence of the GALE gene has been identified. Loss-of-function variants in GALE are known to be pathogenic (PMID: 16301867). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.(?_24122439)_(24144093_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751161" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9838216" TraitType="Disease" MappingType="XRef" MappingValue="C0268601" MappingRef="MedGen">
        <MedGen CUI="C0268601" Name="Deficiency of hydroxymethylglutaryl-CoA lyase" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9838251" TraitType="Disease" MappingType="XRef" MappingValue="C0751161" MappingRef="MedGen">
        <MedGen CUI="C0751161" Name="UDPglucose-4-epimerase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

